Fluidigm Joins Global Consortium of Cancer Prevention Experts

NEXT STORY
Arcutis Completes Enrollment in DERMIS-1 and DERMIS-2 Pivotal Phase 3 Clinical Trials Evaluating ARQ-151 (Topical Roflumilast Cream) as a Potential Treatment for Plaque Psoriasis
PREV STORY
Revive Therapeutics Announces IRB Approval of US Expanded Access Treatment Program (Compassionate Use) for Bucillamine in COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Intercept to Report 2015 Full Year Financial Results on February 23 and Present at Upcoming Conference

NEW YORK, Feb. 17, 2016 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a clinical ...

author_avatar
NASDAQ Market News

Primary Eyecare Associates Welcomes Their Newest Optometrist Dr. Lori Butler

BURKE, Va., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Primary Eyecare Associates announces an addition ...

author_avatar
NASDAQ Market News

Shire plc : CHMP RECOMMENDS EU MARKETING AUTHORIZATION FOR VEYVONDI(R) FOR ADULTS WITH VON WILLEBRAND DISEASE

CHMP RECOMMENDS EU MARKETING AUTHORIZATION FOR VEYVONDI® [VONICOG ALFA, RECOMBINANT VON WILLEBRAND FACTOR] FOR ...

author_avatar
NASDAQ Market News